Bill Would Expand Number of Stem Cell Lines Eligible for Federal Funds

Press Release

Bill Would Expand Number of Stem Cell Lines Eligible for Federal Funds

Rep. Zoe Lofgren (D-San Jose) today voted in favor of S. 5, the bipartisan Stem Cell Research Enhancement Act. This bill expands the number of embryonic stem cell lines eligible to be used for federally-funded research and only authorizes funding for stem cell lines generated from embryos that would otherwise be discarded by fertility clinics. The bill authorizes the Department of Health and Human Services (HHS) to support research involving embryonic stem cells meeting certain criteria, regardless of the date on which the stem cells were derived from an embryo. Current policy limits the use of federal funds for research only to those stem cell lines that existed when President Bush issued an executive order on August 9, 2001.

"This bill will open up countless new avenues for research into cures for some of the most debilitating diseases," commented Rep. Zoe Lofgren. "It's important to note that this legislation only authorizes federal research funds for stem cell lines generated from embryos that would otherwise be discarded by fertility clinics. This measure balances ethical concerns with the needs of our medical and scientific communities. I applaud my colleagues for supporting this bill."

The bill is supported by more than 500 organizations, including the American Medical Association, AARP, Association of American Medical Colleges, Research!America, Parkinson's Action Network, American Diabetes Association, Juvenile Diabetes Research Foundation, and Paralyzed Veterans of America. Faith-based groups supporting the bill include the Episcopal Church, United Church of Christ, Disciples Justice Action Network, and B'nai B'rith International.

Source